Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Moderna to develop three new mRNA vaccines

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it is expanding its mRNA pipeline with three new development...

FDA approves Agios’ mitapivat as first disease-modifying therapy for genetic blood disorder

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug...

Hurry up to book a stand at the business event “Ingredients and Additives” 2022!

Take part in the international conference and exhibition "Ingredients and Additives".In 2022, the event will take place on the territory of Technopark Skolkovo innovation...

Pharmasyntez starts construction of new parenteral nutrition plant in Ussuriysk

The Pharmasyntez Group of companies is going to launch the parenteral (intravenous) nutrition department in Primorye. At a meeting with Oleg Kozhemyako, Governor of Primorsky...

The European Medicines Agency has published key information on human and veterinary medicines for 2021

The overview of key recommendations in 2021 includes figures on the authorisation of medicines and a selection of new treatments, as well as  safety...

Takeda and Resilience enter development deal for plasma meds

The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...
spot_img

Expert Articles

spot_img